Fujirebio is a global leader in the field of high quality in vitro diagnostics (IVD). It has more than 50 years’ accumulated experience in the conception, development, production and worldwide commercialization of robust IVD products. Founded in 1950 in Tokyo, Japan, Fujirebio has over the years concluded a number of successful acquisitions of best-in-class IVD companies. Examples include Centocor Diagnostics in 1998, CanAg Diagnostics in 2006 and Innogenetics in 2010. Today, Fujirebio’s global presence includes offices in the United States, Latin America, Europe and Asia as well as a vast international distribution network. Fujirebio has a strong and long-lasting tradition of collaborating with experts in the worldwide clinical community in the development of high-quality routine and truly novel biomarkers that cover a variety of disease states. Its IVD product lines span the range from specialized manual and automated testing to fully automated routine clinical laboratory testing solutions. Fujirebio is today a consolidated subsidiary of H.U. Group Holdings, Inc. (listed on the Tokyo Stock Exchange – TYO: 4544) and employs more than 1,200 people in Asia, Europe and America.

We are a biopharmaceutical company and wholly owned subsidiary of Alfasigma S.p.A. focused on the development and commercialization of novel therapeutics to treat rare and serious liver diseases, including primary biliary cholangitis (PBC) and severe alcohol-associated hepatitis (sAH). In a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with rare and serious liver disease. We are committed to improving patients’ lives and addressing the liver community’s most pressing needs. Our corporate headquarters is located in New Jersey. For more information about Intercept, please visit our website at: www.interceptpharma.com and follow us on X at: @InterceptPharma.

Since 1990 Specified Technologies Inc. (STI) is an industry leader in developing innovative fire protection systems that help stop the spread of fire, smoke, and hot gases. Specified Technologies Inc. has worked closely with the construction industry to create simple solutions to complex firestopping problems. STI has been at the forefront of developing the most advanced and cost-effective firestop solutions on the market, offering premium quality, superior performance, and best-in-class service, training, and support. Our SpecSeal® and EZ-Path® product lines are engineered to deliver powerful performance. Because our system designs are user-driven, they are easier to apply. The result is simply designed, outstanding fire protection systems which often result in lower installed costs. STI products and systems offer innovative firestop solutions for all types of new construction and retrofit applications. Since firestopping is our only business, we concentrate all our resources on providing the highest quality, fully tested, innovative firestopping solutions that are backed with over 1,300 UL® Classified systems; This is more than any firestop company in the world. STI is committed to supporting our customers by providing sustainable firestop solutions, management programs for firestop, treating them like partners, and by consistently adding value beyond the sale. Whether you are an architect, a contractor, or an installer…you can depend on STI to deliver knowledgeable advice, premium quality products, and the total firestop solution.

In 1959, entrepreneur Robert H. Dallas formed what was to become one of the larger privately-owned chemical companies in the United States. In 1989, a newly formed Dallas Group of America, Inc. was established as a spin-off and grew into a diversified manufacturer of basic and specialty chemicals. The Dallas Group produces the highest quality MAGNESOL® and DALSORB® synthetic magnesium silicates, ammonium chloride, ammonium sulfate, and lignosulfonates and serves customers in more than 100 countries. The company operates multiple manufacturing and packaging facilities in North America, China, and Europe. The Dallas Group’s laboratories are staffed with degreed chemists, engineers, and technicians performing more than 50,000 tests each year to ensure that all products and raw materials meet specifications for quality and purity. Selected staff routinely participate in the AOCS Approved Chemists Program and have been awarded Proficiency Program Winner status in AOCS’s NIOP Fats and Oils Program numerous times. Our production facilities are GMP-certified, ensuring that our products are consistently produced and controlled according to quality standards.

Piramal Critical Care (PCC), a business division of Piramal Pharma Limited (PPL) is one of the leaders in inhaled anesthetics and a global player in hospital generics. “Saving and improving patients’ lives” is much more than a purpose statement to us. We are motivated by our vision of commitment to delivering critical care solutions for patients and healthcare providers, while achieving sustainable and profitable growth for all the stakeholders. Piramal Critical Care maintains a wide presence across the US, Europe and more than 100 countries across the globe. Our product portfolio includes inhalation anesthetics, intrathecal therapy for spasticity management, injectable pain and anesthesia drugs, injectable anti-infectives, oral therapy for Type I Gaucher and Niemann pick Type C disease, anticholinergic, plasma volume expander, non-depolarizing neuromuscular blocking agent, depolarizing skeletal muscle relaxant and an anxiolytic, sedative and pain medication. Our products include Sevoflurane, Desflurane, Isoflurane, Halothane, Gablofen® (Baclofen Injection), MITIGO™(Morphine Sulfate), Dipidolor® (Piritramide), Sublimaze® (Fentanyl Citrate), Rapifen® (Alfentanil Hydrochloride), Sufenta® (Sufentanil Citrate), Hypnomidate®(Etomidate), Ampicillin and Sulbactam for Injection, USP, Cefepime for Injection, USP, Ceftriaxone for Injection, USP, Linezolid Injection, Ampicillin for Injection, USP, Piperacillin and Tazobactam for Injection, USP, Yargesa™ (Miglustat), Glycopyrrolate, Haemaccel, Rocuronium Bromide Injection, Succinylcholine Chloride Injection, USP, Dexmedetomidine Injection, USP, Dexmedetomidine HCl in 0.9% Sodium Chloride Injection (RTU*) and Propofol- Lipuro emulsion for Injection or Infusion. PCC has strong manufacturing and process development experience. PCC has fully owned manufacturing facilities in Bethlehem, PA, USA and Digwal, India. Customer centricity is the cornerstone of our business. *RTU Ready to use

Recordati Rare Diseases Inc. (RRD) markets products to treat rare diseases. RRD is a member of the Recordati Group, which includes Recordati S.p.A., Orphan Europe, among other companies around the globe. The Recordati Group, which was established in 1926 currently employs more than 4,000 worldwide. The RRD mission is to reduce the impact of extremely rare and devastating diseases by providing urgently needed therapies. We work side-by-side with rare disease communities to increase awareness, improve diagnosis and expand availability of treatments for people with rare diseases.

Amarin is an innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. We are committed to increasing the scientific understanding of the cardiovascular risk that persists beyond traditional therapies and advancing the treatment of that risk for patients worldwide. Amarin has offices in Bridgewater, New Jersey in the United States, Dublin in Ireland, Zug in Switzerland, and other countries in Europe as well as commercial partners and suppliers around the world. For more information, visit www.amarincorp.com. See our Community Guidelines: bit.ly/2L7xEW6

Immunocore is a leading T cell receptor (TCR) biotechnology company working to create first-in-class biological therapies to address unmet patient needs in oncology as well as infectious and autoimmune diseases. See our community guidelines: http://bit.ly/2kFA8hr

Private Label service oriented packaging company. Aerosol and Bulk Packaging available! Automotive Aftermarket Lubricants / Penetrants Cleaners / Degreasers Adhesives Specialty Paints & Coatings Manufacturing in Plymouth Meeting, PA and Medina, OH Distribution in PA, OH and CA.

BioSpectra is a U.S.-based manufacturer of GMP pharmaceutical-grade ingredients, including actives, excipients, GMP process chemicals, and bulk GMP buffers and solutions. Our focus is small molecule synthesis and true, phase-change multi-step purification for both traditional and biopharmaceutical applications. Our services include contract GMP product development, coupled with ongoing commercial manufacturing and regulatory support, up to and including DMF submissions. All of our manufacturing processes are fully validated. Our U.S.-GMP regulatory package complies with IPEC & ICHQ7 guidelines. Onsite analytical testing capabilities include multi-compendial and custom specifications, with full traceability and transparency of all raw materials and sources. Our commitment to quality, compliance and true, U.S.-GMP manufacturing, testing, and regulatory support is unparalleled. Our goal is to be a valued partner in the secure supply chain and the solution to any key ingredient issue our customers may have. GMP Product Categories: • Bulk GMP biological buffers • Active & functional excipients • GMP process chemicals and bulk GMP Solutions Custom GMP Services: • Purification of key ingredients • Full GMP product development • Small molecule custom synthesis • API development and manufacturing • Custom GMP compounded solvents and solutions Comprehensive Quality and Regulatory Program: • FDA registered and inspected • Document support (DMF submissions) • Global GMP requirements (US, IPEC, ICH-Q7)

Spray-Tek is a long-standing industry leader providing custom spray drying and related services for a broad variety of products, including flavors and fragrances, pharmaceuticals, nutraceuticals and vitamins, food ingredients, cosmetics and soft chemicals.